Adeola Davis
Last active: 7/14/2015

Profile

Project Manager with the Vanderbilt-Meharry-Matthew Walker Center of Excellence in Sickle Cell Disease.

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function. Saunders C, Siuta M, Robertson SD, Davis AR, Sauer J, Matthies HJG, Gresch PJ, Airey D, Lindsley CW, Schetz JA, Niswender KD, Veenstra-Vanderweele JM, Galli A (2014) Neurochem Int : 113-121
    › Citation · 24090638 (PubMed) · PMC4073299 (PubMed Central)
  2. Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes. Conrad KL, Davis AR, Silberman Y, Sheffler DJ, Shields AD, Saleh SA, Sen N, Matthies HJ, Javitch JA, Lindsley CW, Winder DG (2012) Neuropsychopharmacology 37(10): 2253-66
    › Citation · 22617356 (PubMed) · PMC3422490 (PubMed Central)
  3. Exendin-4 decreases amphetamine-induced locomotor activity. Erreger K, Davis AR, Poe AM, Greig NH, Stanwood GD, Galli A (2012) Physiol Behav 106(4): 574-8
    › Citation · 22465309 (PubMed) · PMC3348974 (PubMed Central)
  4. Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. Speed N, Saunders C, Davis AR, Owens WA, Matthies HJ, Saadat S, Kennedy JP, Vaughan RA, Neve RL, Lindsley CW, Russo SJ, Daws LC, Niswender KD, Galli A (2011) PLoS One 6(9): e25169
    › Citation · 21969871 (PubMed) · PMC3182178 (PubMed Central)